CD4 T cells in tumor immunity

Gerloni, Mara; Zanetti, Maurizio
June 2005
Springer Seminars in Immunopathology;Jun2005, Vol. 27 Issue 1, p37
Academic Journal
T cell immunity is the key to protective immune responses against tumors. Traditionally, this function has been ascribed to CD8 T lymphocytes with cytotoxic activity, which are restricted by MHC class I molecules. In recent years the realization that CD4 T cells can also play a relevant role in protective anti-tumor responses has received growing attention. Here we will discuss the role of MHC class II-restricted T cells in response to, and in the regulation of, tumor antigens. Emphasis will be placed on four areas: (1) the role of CD4 T cell immunity in tumor protection in animal models and putative mode of action, (2) tumor antigens recognized by human CD4 T cells, (3) the cooperation between two CD4 T cells of different specificity as a new way to jump start the response against sub-immunogenic determinants of tumor antigens in a tolerant environment, and (4) the negative impact of regulatory CD4 T cells on anti-tumor T cell responses. By drawing attention to these four areas, it is our intention to provide the reader with a comprehensive view of issues of contemporary importance for this field, in the expectation that the information will help a better design of therapeutic cancer vaccines.


Related Articles

  • Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/ neu by human dendritic cells. Baleeiro, Renato B; Rietscher, René; Diedrich, Andrea; Czaplewska, Justyna A; Lehr, Claus-Michael; Scherließ, Regina; Hanefeld, Andrea; Gottschaldt, Michael; Walden, Peter // OncoImmunology;Nov2015, Vol. 4 Issue 11, pN.PAG 

    Cross-presentation is the process by which professional antigen presenting cells (APCs) (B cells, dendritic cells (DCs) and macrophages) present endocytosed antigens (Ags) via MHC-I to CD8+T cells. This process is crucial for induction of adaptive immune responses against tumors and infected...

  • In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients. Vries, I. J. M.; Bernsen, M. R.; van Geloof, W. L.; Scharenborg, N. M.; Lesterhuis, W. J.; Rombout, P. D. M.; Van Muijen, G. N. P.; Figdor, C. G.; Punt, C. J. A.; Ruiter, D. J.; Adema, G. J. // Cancer Immunology, Immunotherapy;Oct2007, Vol. 56 Issue 10, p1667 

    Application of tetrameric MHC class I-peptide complexes has significantly improved the monitoring of antigen-specific T cell immune responses in mouse models as well as in clinical studies. Especially MHC class I tetramer analysis of tumor-specific T cells in suspension or on thick vibratome...

  • Defining MHC class II T helper epitopes for WT1 tumor antigen. Kobayashi, Hiroya; Nagato, Toshihiro; Aoki, Naoko; Sato, Keisuke; Kimura, Shoji; Tateno, Masatoshi; Celis, Esteban // Cancer Immunology, Immunotherapy;Jul2006, Vol. 55 Issue 7, p850 

    The product of Wilms‘ tumor gene 1 (WT1) is overexpressed in diverse human tumors, including leukemia, lung and breast cancer, and is often recognized by antibodies in the sera of patients with leukemia. Since WT1 encodes MHC class I-restricted peptides recognized by cytotoxic T...

  • The 'chop-and-change' of MHC class I assembly. Elliott, Tim // Nature Immunology;Jan2006, Vol. 7 Issue 1, p7 

    This article states that the CD8+ T cell recognition of peptides presented by major histocompatibility complex class I molecules is essential for effective antiviral and antitumor immune responses. Cytotoxic T lymphocytes scan a micro-array of peptide-major histocompatibility complex class I...

  • The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions. Garrido, Federico; Algarra, Ignacio; García-Lora, Angel M. // Cancer Immunology, Immunotherapy;Oct2010, Vol. 59 Issue 10, p1601 

    The discovery of tumor antigens recognized by T lymphocytes has stimulated the development of a variety of cancer treatment protocols aimed at enhancing antitumor-specific T cell responses and tumor rejection. However, immunotherapy-mediated regression of established tumors and clearly positive...

  • IL-6, but not IFN-γ, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing. Regis, G.; Icardi, L.; Conti, L.; Chiarle, R.; Piva, R.; Giovarelli, M.; Poli, V.; Novelli, F. // Leukemia (08876924);Nov2009, Vol. 23 Issue 11, p2102 

    STAT1 and STAT3 are the main mediators of the signaling of interferons (IFNs) and of gp130 cytokines, respectively. Neoplastic T lymphocytes frequently become resistant to the IFN-γ/STAT1 apoptotic pathway, often because of the downregulation of the IFN-γR2 receptor chain. Many studies...

  • Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes. Vigneron, Nathalie; Van den Eynde, Benoît // Cellular & Molecular Life Sciences;May2011, Vol. 68 Issue 9, p1503 

    The molecular definition of tumor antigens recognized by cytolytic T lymphocytes (CTL) started in the late 1980s, at a time when the MHC class I antigen processing field was in its infancy. Born together, these two fields of science evolved together and provided each other with critical...

  • Multifaceted roles of MHC class I and MHC class I?like molecules in T cell activation. Ugolini, Sophie; Vivier, Eric // Nature Immunology;Mar2001, Vol. 2 Issue 3, p198 

    Presentation of the multifaceted roles of the major histocompatibility complex (MHC) class I and MHC class I-like molecules in T cell activation. Provision of costimulatory signal and augmentation of the cytotoxic response of MHC through the engagement of NKG2D on CMV specific aα Bβ...

  • Detection and Characterization of Cellular Immune Responses Using Peptide --MHC Microarrays. Soen, Yoav; Chen, Daniel S.; Kraft, Daniel L.; Davis, Mark M.; Brown, Patrick O. // PLoS Biology;Dec2003, Vol. 1 Issue 3, p429 

    The detection and characterization of antigen-specific T cell populations is critical for understanding the development and physiology of the immune system and its responses in health and disease. We have developed and tested a method that uses arrays of peptide-MHC complexes for the rapid...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics